ABSENCE OF FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 IN FINNISH PATIENTS WITH ELEVATED SERUM-CHOLESTEROL

被引:60
|
作者
HAMALAINEN, T
PALOTIE, A
AALTOSETALA, K
KONTULA, K
TIKKANEN, MJ
机构
[1] UNIV HELSINKI,DEPT MED 3,SF-00290 HELSINKI 29,FINLAND
[2] UNIV HELSINKI,DEPT CLIN CHEM,SF-00290 HELSINKI 29,FINLAND
[3] UNIV HELSINKI,RECOMBINANT DNA LAB,SF-00290 HELSINKI 29,FINLAND
关键词
Apolipoprotein B-100; Atherosclerosis; Hypercholesterolemia;
D O I
10.1016/0021-9150(90)90038-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial defective apolipoprotein B-100 is a genetic disorder which is associated with elevated plasma LDL levels. It appears to result from a G → A mutation at nucleotide 10 708 in exon 26 of the apolipoprotein B-100 gene leading to a substitution of glutamine for arginine at amino acid residue 3500. We explored the possible role of this point mutation as a cause of elevated plasma cholesterol among the Finns, a genetically isolated population in which both hypercholesterolemia and coronary heart disease are common: 552 hyperlipidemic patients from Western and Southern Finland were screened either by assaying patient sera with monoclonal antibody MB47 or by amplifying the region of the apo B gene containing the nucleotide 10 708 followed by hybridization of the amplified DNA with allele-specific oligonucleotide probes. Not a single individual with this particular mutation could be found. We conclude that familial defective apo B-100 is not a common cause of elevated plasma cholesterol in this population. © 1990.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [31] PHENOTYPIC HETEROGENEITY ASSOCIATED WITH DEFECTIVE APOLIPOPROTEIN-B-100 AND OCCURRENCE OF THE FAMILIAL HYPERCHOLESTEROLEMIA PHENOTYPE IN THE ABSENCE OF AN LDL-RECEPTOR DEFECT WITHIN A CANADIAN KINDRED
    DAVIGNON, J
    DUFOUR, R
    ROY, M
    BETARD, C
    MA, Y
    OUELLETTE, S
    BOULET, L
    LUSSIERCACAN, S
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 : 10 - 17
  • [33] Familial defective apolipoprotein B-100 in Slovakia Are differences in prevalence of familial defective apolipoprotein B-100 explained by ethnicity?
    Gasparovic, Juraj
    Basistova, Zuzana
    Fabryova, L'ubomira
    Wsolova, Ladislava
    Vohnout, Branislav
    Raslova, Katarina
    [J]. ATHEROSCLEROSIS, 2007, 194 (02) : E95 - E107
  • [34] METABOLISM OF APOLIPOPROTEIN-B-48 AND APOLIPOPROTEIN-B-100 OF TRIGLYCERIDE-RICH LIPOPROTEINS IN PATIENTS WITH FAMILIAL DYSBETALIPOPROTEINEMIA
    STALENHOEF, AFH
    MALLOY, MJ
    KANE, JP
    HAVEL, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03): : 722 - 728
  • [35] Familial defective apolipoprotein B-100: A review
    Andersen, Lars H.
    Miserez, Andre R.
    Ahmad, Zahid
    Andersen, Rolf L.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (06) : 1297 - 1302
  • [36] Familial defective apolipoprotein B100 in Greece
    Koniari, E.
    Laios, E.
    Drogari, E.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 134 - 135
  • [37] IMPROVED DETECTION OF FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 BY RESTRICTION-SITE-INTRODUCING POLYMERASE CHAIN-REACTION
    GEISEL, J
    SCHLEIFENBAUM, T
    WEISSHAAR, B
    OETTE, K
    [J]. CLINICAL CHEMISTRY, 1993, 39 (09) : 2026 - 2027
  • [38] LIPOPROTEIN(A) IN SUBJECTS WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN-B100
    PEROMBELON, YFN
    GALLAGHER, JJ
    MYANT, NB
    SOUTAR, AK
    KNIGHT, BL
    [J]. ATHEROSCLEROSIS, 1992, 92 (2-3) : 203 - 212
  • [39] RAPID DIAGNOSIS OF FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100
    GEISEL, J
    SCHLEIFENBAUM, T
    WEISSHAAR, B
    OETTE, K
    [J]. EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1991, 29 (06): : 395 - 399
  • [40] A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100
    Taylor, Alison
    Bayly, Graham
    Patel, Kunjan
    Yarram, Laura
    Williams, Maggie
    Hamilton-Shield, Julian
    Humphries, Steve E.
    Norbury, Gail
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2010, 47 : 487 - 490